Uncover key drivers, emerging technologies, and competitive movements shaping the pentavalent market from 2025–2034 with trusted insights from The Business Research Company
What Is The Projected Valuation Of The Pentavalent Market In The Period 2029-2034?
The pharmacovigilance and drug safety software market size has experienced rapid expansion in recent years. It is anticipated to increase from $2.26 billion in 2024 to $2.53 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.3%. The historical growth in this market can be linked to the rising demand for pharmacovigilance and drug safety software.
The pharmacovigilance and drug safety software market is projected for significant expansion in the coming years, with its size anticipated to reach $4.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period is primarily fueled by the increasing occurrence of adverse drug reactions, the globalization of pharmacovigilance, the growing complexity of drug safety regulations, and the rising development of new drugs and therapies. Key trends anticipated in this period include the integration of automation and artificial intelligence, the adoption of cloud-based solutions, ongoing technological advancements, and the progressive digitalization of healthcare.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Strategic Drivers Are Accelerating The Pentavalent Market Expansion?
The increasing need for individualized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market in the future. Personalized medicine, also referred to as precision medicine, represents a healthcare strategy where decisions and treatments are customized based on each patient’s unique attributes. This rising demand for personalized medicine stems from multiple elements, including enhanced treatment results, an emphasis on disease prevention and prompt identification, and economic efficiency. Critical for the triumph of personalized medicine are pharmacovigilance and drug safety software solutions. Integrating pharmacogenetics, real-time data interpretation, post-market monitoring, and tailored medication data, these tools enhance the safety and effectiveness of bespoke treatments, simultaneously bolstering strong risk management approaches and confronting ethical concerns. An example illustrates this: in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA cleared 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Consequently, the escalating demand for personalized medicine is fueling the expansion of the pharmacovigilance and drug safety software market.
What Is The Detailed Segment Distribution Of The Pentavalent Market?
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
How Are Global Trends Impacting The Development Of The Pentavalent Market?
Leading companies within the pharmacovigilance and drug safety software market are actively developing novel technologies, such as cloud-based data lake platforms. These innovations aim to bolster patient safety, more efficiently monitor adverse events, and strengthen regulatory compliance across clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform is defined as a scalable, centralized storage system, empowering organizations to house, manage, and analyze extensive volumes of both structured and unstructured data. It facilitates real-time data access and supports sophisticated analytics alongside AI/ML workloads. As an illustration, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled CorEvidence, a proprietary cloud-based data lake platform. This platform was specifically created to improve pharmacovigilance processes within clinical research registries, thereby streamlining case processing and safety data management, particularly for post-authorization safety studies.
Who Are The Major Stakeholders Operating In The Pentavalent Market?
Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies
Download The Full Report Here:
Which Region Is Projected To Achieve The Fastest Growth In The Pentavalent Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp
Browse Through More Reports Similar to the Global Pentavalent Market 2025, By The Business Research Company
Pharmacovigilance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Automotive Safety Systems Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/automotive-safety-systems-global-market-report
Patient Safety And Risk Management Software Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
